InvestorsHub Logo

Uncle Gee Gee

10/15/20 12:30 PM

#26683 RE: Tiger Money #26678

Ahhh... yeah... Relief owns it, and Neuro is helping guide everything through the FDA and then once approved, they get some of the profit from sales. Here's the crux of their partnership agreement:

"They have agreed that NeuroRx will lead commercialization in the United States, Canada, and Israel, while Relief will lead commercialization in Europe and the rest of the world. Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada and Israel, 85/15 (in favor of Relief) in Europe, and 80/20 (in favor of Relief) in all other territories."